

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss


PureTech's Vor Biopharma granted FDA fast track for blood cancer drug


(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approva...


(Sharecast News) - Coats: Jefferies starts at buy with 97.0p target price.


PureTech Health hopes cash will carry it to 2025 amid first half loss


(Sharecast News) - Biotechnology company PureTech Health swung to a loss in its first half, it said on Tuesday, amid rising costs.


IN BRIEF: PureTech Health's LYT-100 performs well in Phase 1


UK earnings, trading statements calendar - next 7 days